Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
7.61
+0.26 (3.54%)
At close: Mar 2, 2026, 4:00 PM EST
7.49
-0.12 (-1.58%)
Pre-market: Mar 3, 2026, 8:51 AM EST
Cybin Employees
Cybin had 50 employees as of March 31, 2025. The number of employees did not change compared to the previous year.
Employees
50
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,464,346
Market Cap
380.77M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 50 | 0 | - |
| Mar 31, 2024 | 50 | 0 | - |
| Mar 31, 2023 | 50 | 0 | - |
| Mar 31, 2022 | 50 | 12 | 31.58% |
| Mar 31, 2021 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ginkgo Bioworks Holdings | 834 |
| Aura Biosciences | 109 |
| Neurogene | 107 |
| Aclaris Therapeutics | 64 |
| Armata Pharmaceuticals | 60 |
| Atea Pharmaceuticals | 56 |
| Candel Therapeutics | 38 |
| NovaBridge Biosciences | 32 |
HELP News
- 6 days ago - HELUS Pharma: Transitioning From Psychedelic Research To Late-Stage Clinical Neuroscience - Seeking Alpha
- 7 days ago - Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee - GlobeNewsWire
- 14 days ago - Nature Medicine Publishes Helus Pharma's Randomized, Placebo-Controlled Phase 2a Trial of SPL026 in Major Depressive Disorder - GlobeNewsWire
- 18 days ago - HELUS Pharma Reports Third Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - Cybin Initiates At-The-Market Equity Program of up to US$100 Million - Business Wire
- 2 months ago - Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq - Business Wire
- 3 months ago - Cybin Inc. (CYBN) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights - Business Wire